Your browser doesn't support javascript.
loading
Differences in maternal gene expression in Cesarean section delivery compared with vaginal delivery.
Kothiyal, Prachi; Schulkers, Keriann; Liu, Xinyue; Hazrati, Sahel; Vilboux, Thierry; Gomez, Luis M; Huddleston, Kathi; Wong, Wendy S W; Niederhuber, John E; Conrads, Thomas P; Maxwell, G Larry; Hourigan, Suchitra K.
Afiliación
  • Kothiyal P; Inova Health System, Falls Church, VA, USA. pkothiyal@symbioseq.com.
  • Schulkers K; Inova Children's Hospital, Falls Church, VA, USA.
  • Liu X; Inova Health System, Falls Church, VA, USA.
  • Hazrati S; Inova Health System, Falls Church, VA, USA.
  • Vilboux T; Persona Biomed, Inc., Alexandria, VA, USA.
  • Gomez LM; Women's Service Line and the Women's Health Integrated Research Center, Inova Health System, Falls Church, VA, USA.
  • Huddleston K; Inova Health System, Falls Church, VA, USA.
  • Wong WSW; College of Health and Human Services, George Mason University, Fairfax, VA, USA.
  • Niederhuber JE; Inova Health System, Falls Church, VA, USA.
  • Conrads TP; Departments of Surgery and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Maxwell GL; Women's Service Line and the Women's Health Integrated Research Center, Inova Health System, Falls Church, VA, USA.
  • Hourigan SK; Women's Service Line and the Women's Health Integrated Research Center, Inova Health System, Falls Church, VA, USA.
Sci Rep ; 10(1): 17797, 2020 10 20.
Article en En | MEDLINE | ID: mdl-33082495
ABSTRACT
Cesarean section (CS) is recognized as being a shared environmental risk factor associated with chronic immune disease. A study of maternal gene expression changes between different delivery modes can add to our understanding of how CS contributes to disease patterns later in life. We evaluated the association of delivery mode with postpartum gene expression using a cross-sectional study of 324 mothers who delivered full-term (≥ 37 weeks) singletons. Of these, 181 mothers had a vaginal delivery and 143 had a CS delivery (60 with and 83 without labor). Antimicrobial peptides (AMP) were upregulated in vaginal delivery compared to CS with or without labor. Peptidase inhibitor 3 (PI3), a gene in the antimicrobial peptide pathway and known to be involved in antimicrobial and anti-inflammatory activities, showed a twofold increase in vaginal delivery compared to CS with or without labor (adjusted p-value 1.57 × 10-11 and 3.70 × 10-13, respectively). This study evaluates differences in gene expression by delivery mode and provides evidence of antimicrobial peptide upregulation in vaginal delivery compared to CS with or without labor. Further exploration is needed to determine if AMP upregulation provides protection against CS-associated diseases later in life.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cesárea / Parto Obstétrico / Proteínas Citotóxicas Formadoras de Poros Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cesárea / Parto Obstétrico / Proteínas Citotóxicas Formadoras de Poros Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos